Results 271 to 280 of about 444,703 (391)

The psychosis spectrum in Parkinson disease

open access: yesNature Reviews Neurology, 2017
D. Ffytche   +6 more
semanticscholar   +1 more source

Associations between higher exposure to potentially morally injurious events and negative posttraumatic cognition trajectories throughout cognitive processing therapy

open access: yesJournal of Traumatic Stress, EarlyView.
Abstract Individuals with higher potentially morally injurious event (PMIE) exposure often exhibit elevated levels of negative posttraumatic cognitions (NPCs). Researchers have argued that individuals with moral injury (MI) following PMIE exposure experience more prescriptive NPCs than those without MI.
Anusha M. Limdi   +4 more
wiley   +1 more source

Letter to the Editor. [PDF]

open access: yesPsychol Med
Raikkerus H.
europepmc   +1 more source

Loneliness in Psychosis: A Meta-analytical Review

open access: yesSchizophrenia bulletin, 2018
Beata Michalska da Rocha   +3 more
semanticscholar   +1 more source

A 1‐year follow‐up of the My Grief app for prolonged grief

open access: yesJournal of Traumatic Stress, EarlyView.
Abstract Mobile health applications (apps) are increasingly used to reduce mental health problems. However, few effective apps are available for bereaved adults. Recently, a randomized controlled trial demonstrated the short‐term beneficial effects of access to the My Grief app in mitigating symptoms of prolonged grief and posttraumatic stress in ...
Maarten C. Eisma   +5 more
wiley   +1 more source

Lack of evidence to favor specific preventive interventions in psychosis: a network meta‐analysis

open access: yesWorld Psychiatry, 2018
C. Davies   +7 more
semanticscholar   +1 more source

Levodopa–Entacapone–Carbidopa Intrajejunal Infusion in Advanced Parkinson's Disease – Interim Analysis of the ELEGANCE Study

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Levodopa–entacapone–carbidopa intestinal gel (LECIG) was introduced in 2018 as a device‐aided therapy for advanced Parkinson's disease (PD). Objectives The ELEGANCE study (NCT05043103) is gathering real‐world data on long‐term efficacy, safety and patient‐reported outcomes with LECIG from 13 European countries.
Daniel Weiss   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy